Investing in Health
Focused on healthcare and life sciences companies
We partner with management teams and provide capital and guidance as we seek to accelerate the growth of their businesses for the benefit of all stakeholders and patients.
Featured
Portfolio Companies
Partnering with highly experienced management teams, we strategically guide and support their successes as we seek to lead growing, strong revenue-generating healthcare companies.
Germfree
Modular and mobile cleanroom and biocontainment facilities for pharmaceutical, biotech companies and hospitals
Boiron
French natural medicine company offering a portfolio of natural, science-based innovative and personalized pharmaceutical products
Enercon Technologies
Electronics product development and contract manufacturing partner specializing in medical devices
Prolacta
Pharmaceutical-grade human milk processing for premature babies in hospital neonatal intensive care units
Sectors of Focus
Pharmaceuticals
Expanding specialty pharma sector, increasing sales of biologics and generics, and robust M&A market are supported by increasing insurance coverage and innovation within the pharmaceuticals sector
MedTech
Driven by a focus on healthcare outcomes and cost-effectiveness, technological advancements and a positive regulatory environment are merging within the convergence of IT and medical devices
Tech-Enabled Services
With increasing emphasis on personalized and remote care, tech-enabled services leverage advanced technologies through better monitoring, data analysis and personalized treatment options
Ryan Marcotte
“Enercon is excited to partner with EW Healthcare for the next stage of our company’s growth,” said Ryan Marcotte, CEO at Enercon Technologies. “EW enhances Enercon’s already strong financial and operational position by providing expertise in Enercon’s core end markets of Healthcare and MedTech. EW shares our vision of growing Enercon as a platform and they align with our values and culture that our employees are our most important asset. We are thrilled to have EW as our partner.”
Tony Koblish
“I have worked across two companies with EW as largest shareholder with great success. EW offers tremendous depth, experience, and passion for building top-shelf MedTech companies that help surgeons help patients. EW partners with management in a truly value added collaboration process with competency and mutual respect. I consider EW a top investment partner.”
Peter Van Haur
“EW has become a trusted partner as we work to grow the VitalConnect business. The expertise, insights and extensive relationships they have brought have been instrumental across multiple aspects of diligence, commercialization and funding which has allowed us to grow shareholder value together.”
Ted Davis
“The EW team has been a terrific partner for us at BioTissue. In addition to EW’s expertise and commitment to the regenerative medicine space, the firm has an intentional approach of bringing specific skill sets to each portfolio company. EW’s Board representation includes operating perspective and financial/investment expertise, which provides a robust foundation for our Board as we drive our strategic transformation at BioTissue. Shaunak and Bob have been great partners for our Founders, our co-investors and our management team, willing to simply weigh in as a sounding board or “roll up their sleeves” when needed.”
Joseph Capper
“EW Healthcare has been a trusted partner of ours for several years, and we appreciate their support in working toward a shared vision of patient-centered innovation in healthcare. In my time as CEO at MIMEDX, the team at EW has offered valuable strategic counsel at the board level and contributed meaningfully to our growth story.”
Morris Miller
“We are thrilled to partner with EW. With their understanding of the medical device space and how companies should operate, EW has added value from ‘Day 1’. We were very impressed with the careful diligence conducted by the EW team, and we look forward to a great future together!”
Nancy Lurker
“I am so pleased with our working relationship and the experience, guidance and support that EW provides to EyePoint Pharmaceuticals. The quality of their input, at both the Board level and the management level, has been superb and we have forged a true partnership.”
Karen Zaderej
“The EW team is extremely knowledgeable, and their ability to identify great innovations and market opportunities, and help move those innovations forward by sharing expertise and assisting in business plan execution is remarkable. AxoGen is proud to have Essex as a partner in our continued growth.”
Bryan Morton
“EW Healthcare Partners is not so much an Investor as a Partner in building successful businesses as was my experience with EUSA.”
Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.
Latest News & Insights
FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
DUARTE, California—/PRNewswire/—Prolacta Bioscience, the...
EW Healthcare Partners Announces Leadership Evolution
• Dr. Petri Vainio to become Executive Chairman • Dr. Evis...
Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
London, United Kingdom –– Ascend Advanced Therapies...